ESTIMATED LAUNCH DATE* Sensipar cinacalcet Amgen Mar 2018 Endocrine Disorders High. Altoprev lovastatin ER Andrx Mar 2018 High Blood Cholesterol Low

Similar documents
OptumRx generic pipeline forecast

OptumRx generic pipeline forecast

OptumRx generic pipeline forecast

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary

3 Tier Formulary Additions

NEW PATENTED MEDICINES REPORTED TO PMPRB 2011 (UPDATE AS OF NOVEMBER 30, HIGHLIGHTED)

2014 DTC National Advertising Awards Finalists

STEP THERAPY CRITERIA

Aetna Better Health of Illinois Medicaid Formulary Updates

INSIGHT on the Issues

US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

STEP THERAPY CRITERIA

High-Cost Drug Exclusions

Health Partners Medicare Prime 2019 Formulary Changes

November 2016 NASDAQ: ATRS

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit

Managing the Unmanageable

Quarterly pharmacy formulary change notice

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Memorial Hermann Advantage HMO February 2019 Formulary Addendum

Quarterly pharmacy formulary change notice

J Jubilant Pharma Group, catering to Dosage

High-Cost Drug Exclusions

ACYCLOVIR OINT (CCHP2017)

Step Therapy Criteria

Quarterly pharmacy formulary change notice

Pharmacy and Therapeutics (P&T) Committee Provider Update

2019 Drug List Negative Changes

CONTACT POLPHARMA GROUP POLPHARMA B2B

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

formulations Product List- row

Step Therapy Medications

Ontario Drug Benefit Formulary/Comparative Drug Index

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PERSPECTIVE RXPIPELINE

ACYCLOVIR OINT (CCHP2017)

Health Net Health Plan of Oregon, Inc. Oregon Drugs with a quantity limit Effective January 1, 2015 (Published December 15, 2014)

TRICARE Uniform Formulary. Pre-Authorization Requirements

Quarterly pharmacy formulary change notice

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Pharmacy Clinical Prior Authorization Assistance Chart Effective February 2018

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Medication and Dose 10/04/ /05/2016 Total % Change Since 10/2012 ABILIFY 10 MG TABLET $18.76 $ %

September 2018 Pharmacy & Therapeutics Committee Decisions

2016 PRESCRIPTION DRUG LIST UPDATES

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

PULMONARY ARTERIAL HYPERTENSION AGENTS

Neighborhood Medicaid Formulary Changes: June 2017

2014 Quantity Limits (QL) Criteria

Novartis Pharmaceuticals Corporation - US Postmarketing Commitments Ongoing [October 2018]

New & Projected Patent Expirations

Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016

ACYCLOVIR OINT (CCHP2017)

VOMITING INTESTINAL GAS CONSTIPATION DIARRHEA TABLE 1 CAUSES OF DIARRHEA GASTROINTESTINAL TRACT WALL DISORDERS...

MEDICAID QUANTITY LIMIT DRUG LIST

Johnson & Johnson Consumer Inc. et al.; Withdrawal of Approval of 7 New Drug Applications

2019 Drug List Negative Changes

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

Updates to the Alberta Drug Benefit List. Effective September 1, 2018

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

Quarterly pharmacy formulary change notice

Price Changes advised by Pharmac As at 12 June 2015

Kansas EMS Naloxone (Narcan) Administration

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Novartis Pharmaceuticals Corporation - US Postmarketing Commitments October 2016 (Ongoing)

UPMC for You Pharmacy and Therapeutics Committee Meeting July 27, 2010 meeting

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

OHIO MEDICAID PHARMACY COVERAGE

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

AETNA BETTER HEALTH January 2017 Formulary Change(s)

ABILIFY ABILIFY DISCMELT ACTONEL ACTOPLUS MET ACTOPLUS MET XR ACTOS ADCIRCA ADVAIR DISKUS ADVAIR HFA

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

Oregon Health Plan prescription benefit updates

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

STEP THERAPY ALGORITHMS PUP Select Formulary

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

Tribute 2018 Formulary 2018 Quantity Limit Criteria

ATYPICAL ANTIPSYCHOTICS

See Important Reminder at the end of this policy for important regulatory and legal information.

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada,

PHARMACY TIMES BY IEHP PHARMACEUTICAL SERVICES DEPARTMENT September 23, 2013

LIST OF DRUGS DURING 2004

Transcription:

Topicort 0.25% Topical Spray desoximetasone topical spray Taro Mar 2018 Skin Sensipar cinacalcet Amgen Mar 2018 Endocrine Disorders High Altoprev lovastatin ER Andrx Mar 2018 High Blood Cholesterol Ketek telithromycin Sanofi Apr 2018 Infections NuvaRing EE / etonogestrel Organon Apr 2018 Contraceptives Invega Trinza paliperidone palmitate Adcirca tadalafil Lilly May 2018 Janssen May 2018 Mental/Neuro Disorders Moderate Abstral fentanyl SL tablet Prostrakan June 2018 Pain and Inflammation Onexton Gel EpiPen Auto- Injector benzoyl peroxide; clindamycin phosphate High Valeant June 2018 Acne epinephrine Mylan 1H2018 Misc. Moderate Zortress everolimus Novartis 1H 2018 Cancer Moderate Acanya Gel benzoyl peroxide/ clindamycin Letairis ambrisentan Gilead Jul 2018 Dow Pharma Jul 2018 Acne Ampyra dalfampridine Acorda Jul 2018 Multiple Sclerosis High MoviPrep polyethylene glycol 3350 Salix Sep 2018 Constipation Cialis tadalafil Lilly Sep 2018 Circulatory Disorders High Moderate Levitra vardenafil Bayer 3Q2018 Circulatory Disorders Moderate Staxyn vardenafil ODS Bayer Oct 2018 Impotence Moderate Finacea Gel azelaic acid topical gel Bayer Nov 2018 Acne Rapaflo silodosin Actavis 4Q 2018 Urinary Disorders Moderate Pylera biskalcitrate, metronidazole, tetracycline Canasa mesalamine Allergan Dec 2018 Elidel pimecrolimus cream Axcan 4Q2018 GI Novartis Dec 2018 Skin

Advair Diskus salmeterol / fluticasone AndroGel 1.62% testosterone gel Unimed 2018 GlaxoSmithKline 2018 Asthma High Astagraf XL tacrilimus Astellas 2018 Transplant AzaSite azithromycin drops Inspire 2018-2019 Eye Infections Byetta exenatide Inj AstraZeneca 2018 Diabetes Delzicol mesalamine Warner Chilcott 2Q 2018 Durezol difluprednate Sirion 2018-2019 Eye Drugs Fentora Flector fentanyl buccal tablet diclofenac epolamine High Teva 2018-2019 Pain and Inflammation Moderate INST Biochem 2018-2019 Pain and Inflammation Moderate Forfivo XL bupropion XL Edgemont 2018 Depression Ganirelix ganirelix acetate Organon 2018 Infertility Moderate Invanz ertapenem Merck 2018 Infections Lotemax Gel loteprednol etabonate Minivelle estradiol Noven 2018-2019 Valeant 2018 Eye Drugs Moxeza moxifloxacin Alcon 2018-2019 Infections Potiga ezogabine GlaxoSmithKline 2018-2019 Seizures Prestalia amlodipine / perindopril Symplmed 2018-2019 High Blood Pressure/ Heart Disease ProAir HFA albuterol MDI Teva 4Q 2018-2019 Asthma High Proventil HFA albuterol inhaler, HFA Merck 2018-2019 Asthma High Quillivant XR methylphenidate ER Pfizer 2018-2019 ADHD Renagel sevelamer Genzyme 2018 GI Disorders Rescula Restasis unoprostone isopropyl cyclosporin ophthalmic Sucampo 2018-2021 Glaucoma Allergan 2018-2019 Dry Eyes Moderate Samsca tolvaptan Otsuka 2018-2019 Endocrine Disorders

Sprix ketorolac tromethamine Egalet 2018 Pain Suprenza phentermine Citius Pharma 2018 Weight Loss Torisel temsirolimus Pfizer 2018-2019 Cancer Tracleer bosentan Actelion 2018-2019 Travatan Z travoprost Alcon 2018-2019 Glaucoma Trisenox arsenic trioxide Cephalon 2018 Cancer Uceris budesonide Santarus 2018 Viread (150, 200, 250mg) Moderate tenofovir Gilead 2018 HIV Moderate Zytiga abiraterone acetate Centocor 2018-2019 Cancer Moderate Zyclara imiquimod cream MEDICIS Jan 2019 Skin Latuda lurasidone Sunovion Jan 2019 Mental/Neuro Disorders Moderate Tekturna Solodyn (55, 80, 105mg) aliskiren hemifumarate Novartis Jan 2019 High Blood Pressure/ Heart Disease minocycline MEDICIS Feb 2019 Infections Moderate Ranexa ranolazine CV Therapeutics Feb 2019 Heart Disease Emend fosaprepitant Merck Mar 2019 Nausea/Vomiting Moderate Narcan Nasal Spray naloxone Adapt Mar 2019 Antidotes Moderate Symlin pramlintide acetate Amylin Mar 2019 Diabetes Faslodex fulvestrant AstraZeneca Mar 2019 Cancer Moderate Vesicare solifenacin Astellas Apr 2019 Urinary Disorders Exjade deferasirox Novartis 1Q 2019 Iron Toxicity High Cetrotide cetrorelix Serono Apr 2019 Infertility Rescriptor 200mg Abelcet Sporanox Oral Solution delavirdine Pfizer Jun 2019 HIV amphotericin B lipid complex Sigma Tau Jun 2019 Fungal Infections iitraconazole Janssen Jun 2019 Fungal Infections

Lyrica pregabalin Pfizer Jun 2019 Pain and Inflammation High Vivlodex meloxicam Iroko Jul 2019 Pain and Inflammation Firazyr icatibant acetate Shire Jul 2019 Hereditary Angioedema Relistor tablets methylnaltrexone bromide Salix Jul 2019 Constipation Forteo teriparatide Lilly 1H 2019 Osteoporosis High Thalomid thalidomide Celgene Aug 2019 Cancer Gilenya fingolimod Novartis Aug 2019 Multiple Sclerosis Moderate Striant testosterone ER buccal tablet Actient Aug 2019 Cystaran cysteamine hcl Sigma Tau Oct 2019 Eye Jadenu deferasirox Novartis Oct 2019 Iron Toxicity High Synribo omacetaxine IVAX Oct 2019 Cancer Treanda bendamustine Cephalon Nov 2019 Cancer Moderate Osmoprep sodium phosphate Salix Nov 2019 Constipation Endometrin progesterone Ferring Nov 2019 Vaginal Disorders Veletri epoprostenol sodium Actelion Nov 2019 Vaprisol conivaptan Astellas Dec 2019 Endocrine Disorders Aptensio XR methylphenidate Rhodes Dec 2019 Attention Disorders Syndros dronabinol Insys Dec 2019 HIV Diclegis doxylamine & pyridoxine Duchesnay 2019-2020 Nausea/Vomiting Moderate Neupro rotigotine Schwarz Pharma 2019-2028 Parkinson s Disease Prepopik citric acid / magnesium oxide / sodium picosulfate Ferring 2H 2019 Bowel Prep Rozerem ramelteon Takeda 2019 Sleep Disorders Tarceva erlotinib OSI Pharma 2019-2020 Cancer Uceris Foam budesonide Santarus 2019 GI Disorders

Ulesfia benzyl alcohol topical lotion Shionogi 2019-2021 Skin Infections Velcade bortezomib Millennium 2019-2022 Cancer Moderate *Estimated launch dates are subject to change at any time due to legal proceedings, exclusivity, timing of FDA approvals, additional patents, etc. References: FDA Electronic Orange Book. Available at: http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm. Accessed June 7, 2017. Drugs@FDA. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm. Accessed June 7, 2017.